CHICAGO — In this video, Ian W. Flinn, MD, PhD, discusses the phase 2 MorningSun study evaluating fixed-duration subcutaneous mosunetuzumab in patients with previously untreated, high-tumor ...

Nine Inch Nails kicked off their “Peel It Back World Tour” this past week, and based on the early returns it certainly looks to be one of the more kick-ass concerts of 2025. Already we’ve seen Trent ...

In July 2020, Monjuvi in combination with lenalidomide received FDA approval for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise ...

Tafasitamab was previously approved with lenalidomide for r/r diffuse large B-cell lymphoma not otherwise specified and ineligible for autologous stem cell transplant. The inMIND trial randomized ...

Follicular Lymphoma: A Slow-Growing Blood Cancer Courtney Liniewski, from Wisconsin, was diagnosed with Follicular Lymphoma, a slow-growing blood cancer and rare type of non-Hodgkin lymphoma, a few ...

Whether or not “recession nails” measure economic health, they clearly tap into a broader sense of uncertainty — and the collective response to it. Economically, things are uncertain.

Nathan James describes his music, somewhat tongue-in-cheek, as "Nu Nu-Metal," and he fully leans into those roots with his latest single. Titled "Nails," the song features late-Nineties nu-dustrial ...

Follicular lymphoma represents up to 30% of non-Hodgkin lymphoma. It has historically been challenging to treat given its tendency for frequent relapse and potential to turn into large B-cell ...

Nine Inch Nails played the second show of their “Peel It Back World Tour” on Tuesday night (June 17th) in Manchester, England, and offered up a couple of surprises right at the start of the 19-song ...

Incyte Announces FDA Approval of Monjuvi® (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma - Monjuvi® (tafasitamab ...